The Neurological Disorders Research Department is offering the NeuroNEXT Small Business Innovation Research (SBIR) grant. This grant is designed to support small business concerns in conducting biomarker validation or exploratory clinical trials for various neurological disorders. Eligible projects include studies on drugs, biologics, surgical therapies, or medical devices. The primary purpose of this funding is to generate essential data and provide the necessary justification to inform and design subsequent Phase III clinical trials aimed at confirming the efficacy of treatments for neurological diseases. This initiative leverages a cooperative agreement mechanism, ensuring that funded projects are milestone-driven and focused on critical advancements.
Opportunity ID: 123854
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-11-345 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Sep 21, 2011 |
| Last Updated Date: | Mar 12, 2014 |
| Original Closing Date for Applications: | Aug 01, 2014 |
| Current Closing Date for Applications: | Dec 02, 2014 |
| Archive Date: | Jan 02, 2015 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices for neurological disorders which may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III clinical trial) in the treatment of neurologic disease. The program will utilize the cooperative agreement mechanism to enable milestone-drive projects. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-11-345.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modified Archive Date based on new Expiration Date, per NOT-NS-14-012. | Mar 12, 2014 | |
| Mar 12, 2014 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-11-345 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Sep 21, 2011 |
| Last Updated Date: | Mar 12, 2014 |
| Original Closing Date for Applications: | Aug 01, 2014 |
| Current Closing Date for Applications: | Dec 02, 2014 |
| Archive Date: | Jan 02, 2015 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices for neurological disorders which may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III clinical trial) in the treatment of neurologic disease. The program will utilize the cooperative agreement mechanism to enable milestone-drive projects. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-11-345.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-11-345 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 12, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 01, 2014 |
| Archive Date: | Sep 01, 2014 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices for neurological disorders which may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III clinical trial) in the treatment of neurologic disease. The program will utilize the cooperative agreement mechanism to enable milestone-drive projects. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-11-345.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.853 | ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00079270 | Nov 02, 2011 | Dec 02, 2014 | View |
Package 1
Mandatory forms
123854 RR_SF424_1_2-1.2.pdf
123854 PerformanceSite_1_4-1.4.pdf
123854 RR_OtherProjectInfo_1_3-1.3.pdf
123854 RR_KeyPersonExpanded_1_2-1.2.pdf
123854 RR_Budget-1.1.pdf
123854 PHS398_CoverPageSupplement_1_4-1.4.pdf
123854 PHS398_ResearchPlan_1_3-1.3.pdf
123854 PHS398_Checklist_1_3-1.3.pdf
123854 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
123854 RR_SubawardBudget30-1.2.pdf
123854 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
